These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 9607733)
1. Invasive fungal infections in patients receiving intensive cytotoxic therapy for cancer. Bow EJ Br J Haematol; 1998 May; 101 Suppl 1():1-4. PubMed ID: 9607733 [No Abstract] [Full Text] [Related]
2. Phaeohyphomycosis in a tertiary care cancer center. Ben-Ami R; Lewis RE; Raad II; Kontoyiannis DP Clin Infect Dis; 2009 Apr; 48(8):1033-41. PubMed ID: 19267655 [TBL] [Abstract][Full Text] [Related]
3. [Bacterial and mycotic infections in immunosuppressed patients: studies during antineoplastic therapy]. Montagna MT; Larocca AM; Barbuti S Nuovi Ann Ig Microbiol; 1987; 38(1-2):107-15. PubMed ID: 3504269 [No Abstract] [Full Text] [Related]
4. Considerations in the approach to invasive fungal infection in patients with haematological malignancies. Bow EJ Br J Haematol; 2008 Jan; 140(2):133-52. PubMed ID: 18173752 [TBL] [Abstract][Full Text] [Related]
5. Infections in patients with multiple myeloma. Nucci M; Anaissie E Semin Hematol; 2009 Jul; 46(3):277-88. PubMed ID: 19549580 [TBL] [Abstract][Full Text] [Related]
7. A controlled clinical trial of itraconazole for prevention of fungal infections secondary to chemotherapy. Wang CY; Wu BY; Guo KY Di Yi Jun Yi Da Xue Xue Bao; 2003 Apr; 23(4):389-90. PubMed ID: 12697487 [TBL] [Abstract][Full Text] [Related]
8. Fungal infections as a complication of therapy for sarcoidosis. Baughman RP; Lower EE QJM; 2005 Jun; 98(6):451-6. PubMed ID: 15879444 [TBL] [Abstract][Full Text] [Related]
9. [Prevention of fungal infections with ketoconazole in cancer patients receiving cytostatic therapy]. König HJ; Georgiou A; Kraft P; Mayer U Mycoses; 1988 Jun; 31(6):324-9. PubMed ID: 3173422 [No Abstract] [Full Text] [Related]
10. Introduction to the updated Australian and New Zealand consensus guidelines for the use of antifungal agents in the haematology/oncology setting, 2008. Slavin MA Intern Med J; 2008 Jun; 38(6b):457-67. PubMed ID: 18588519 [TBL] [Abstract][Full Text] [Related]
11. [Is it possible to prevent mycotic infections in oncology patients?]. Mayer J; Vorlícek J Vnitr Lek; 1994 Dec; 40(12):783-8. PubMed ID: 7839633 [TBL] [Abstract][Full Text] [Related]
12. Pulmonary fungal infection with yeasts and pneumocystis in patients with hematological malignancy. Pagano L; Caira M; Fianchi L Ann Med; 2005; 37(4):259-69. PubMed ID: 16019724 [TBL] [Abstract][Full Text] [Related]
14. [Risk factors for invasive fungal infections during intensive chemotherapy of acute leukemia--retrospective study]. Zupanić-Krmek D; Nemet D; Mrsić M; Bogdanić V; Labar B; Jandrlić M; Kalenić S Acta Med Croatica; 2004; 58(4):275-84. PubMed ID: 15700683 [TBL] [Abstract][Full Text] [Related]
15. [Dermatologic manifestations of infections in pediatric cancer patients]. Ott H; Höger PH Klin Padiatr; 2005 Nov; 217 Suppl 1():S110-9. PubMed ID: 16288357 [TBL] [Abstract][Full Text] [Related]
16. [Therapy of invasive organ mycoses in patients with systemic hematologic diseases]. Karthaus M; Böhme A Wien Med Wochenschr; 2001; 151(3-4):80-8. PubMed ID: 11789423 [TBL] [Abstract][Full Text] [Related]
17. Recommendations for the treatment of established fungal infections. Thursky KA; Playford EG; Seymour JF; Sorrell TC; Ellis DH; Guy SD; Gilroy N; Chu J; Shaw DR Intern Med J; 2008 Jun; 38(6b):496-520. PubMed ID: 18588522 [TBL] [Abstract][Full Text] [Related]